Palladium-103 plaque radiation therapy for macular degeneration: Results of a 7 year study

British Journal of Ophthalmology

Volumn 87, Issue 12, 2003, Pages 1497-1503

  Finger, P T ^a,c   Gelman, Y P ^a   Berson, A M ^a,b   Szechter, A ^b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM 103;

ANGIOGRAPHY; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSIMETRY; FOLLOW UP; HUMAN; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RETINA MACULA DEGENERATION; RETINA MACULOPATHY; TREATMENT OUTCOME; VISUAL ACUITY;

BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; PALLADIUM; RADIATION DOSAGE; RADIOISOTOPES; VISUAL ACUITY;

EID: 0347517735     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.12.1497     Document Type: Article

References (58)

1. Bressler SB, Bressler NM, Fine SL, et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol 1982;93:157-63.
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
3. Bressler NM, Frost LA, Bressler SB, et al. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 1988;106:1537-42.
4. Guyer DR, Fine SL, Maguire MG, et al. Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol 1986;104:702-5.
5. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571-3.
6. Liebowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study Monograph; an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24(Suppl):335-610.
7. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-41.
8. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-57.
9. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-8.
10. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Arch Ophthalmol 1994;112:489-99.
11. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-31.
12. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 1999;117:1329-45.
13. Bressler NM, Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001;119:198-207.
14. Yannuzzi LA. A new standard of care for laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Data revisited. Arch Ophthalmol 1994;112:462-4.
15. Sharma S, Brown GC, Brown MM, et al. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2001;108:2051-9.
16. Chakravarthy U. External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis or phase-I data. Br J Radiol 2000;73:305-13.
17. Bergink GJ, Hoyng CB, Vandermaazen RWM, et al. A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration - radiation versus observation. Graefes Arch Clin Exp Ophthalmol 1998;236:321-5.
18. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study. Br J Ophthalmol 1993;77:265-73.
19. Char DH, Irvine AI, Posner MD, et al. Randomized trial of radiation for age-related macular degeneration. Am J Ophthalmol 1999;127:574-8.
20. Holz FG, Engenhart-Cabillic R, Unnebrink K, et al. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD study). Ophthalmology 1999;106:2239-47.
21. Marcus DM, Sheils W, Johnson MH, et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized trial. Arch Ophthalmol 2001;119:171-80.
22. Valmaggia C, Reis G, Ballinari P. Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial. Am J Ophthalmol 2002;133:521-9.
23. Jaakola A, Heikkonen J, Tomilla P, et al. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1998;236:24-30.
24. Yonemoto LT, Slater JD, Friedrichsen EJ, et al. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: Treatment techniques and preliminary results. Int J Radiat Oncol Biol Phys 1996;36:867-71.
25. Jaakola A, Heikkonen J, Tarkkanen A, et al. Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choriodal neovascularization. Acta Ophthalmol Scand 1998;76:1-5.
26. Finger PT, Berson A, Sherr DA, et al. Radiation therapy for subretinal neovascularization. Ophthalmology 1996;103:878-89.
27. Berson AM, Finger PT, Sherr DL, et al. Radiation therapy for age-related macular degeneration: preliminary results of a potentially new treatment. Int J Radiat Oncol Biol Phys 1996;36:861-5.
28. Berson A, Finger PT, Chakravarthy U. Radiation therapy for age-related macular degeneration. Sem Radiat Oncol 1999;9:155-62.
29. Finger PT, Immonen I, Freire J, et al. Brachytherapy for macular degeneration associated with subretinal neovascularization. In: Alberti WE, Richard G, Sagerman RH, eds. Age-related macular degeneration: current treatment and concepts. Berlin, Heidelberg, New York: Springer-Verlag, 2000: 167-74.
30. Finger PT, Berson A, Ng T, et al. Ophthalmic plaque radiation therapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-7.
31. Berta A, Vezendi L, Vamosi P. Irradiation of macular subretinal neovascularization using Ruthenium applicators. Szemeset (Hung J Ophthalmol) 1995;132:67-75.
32. Immonen IJ, Jaakaola A, Tommila D, et al. Strontium plaque radiotherapy for exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:S127.
33. Baker DG, Krochak RJ. The response of the microvascular system to radiation: a review. Cancer 1989;7:287-94.
34. Chakravarthy U, Gardiner TA, Archer DB, et al. A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds. Curr Eye Res 1989;8:337-48.
35. Chakravarthy U, Biggart JH, Gardiner TA, et al. Focal irradiation of perforating eye injuries. Curr Eye Res 1989;8:1241-50.
36. Maison JR. The influence of radiation on blood vessels and microcirculation: III Ultrastructure of the vessel wall. Curr Top Radiat Res 1974;10:29-57.
37. Langley RE, Bump EA, Quartuccio SG, et al. Radiation-induced apoptosis in microvascular endothelial cells. Br J Cancer 1997;75:666-72.
38. Barendsen GW. Dose fractionation, dose rate and the iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982;8: 1981-97.
39. Finger PT, Chakravarthy U. External beam radiation therapy is effective in the treatment of age-related macular degeneration. Arch Ophthalmol 1998;116:1507-9.
40. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
41. Hart PM, Archer DP, Chakravarthy V. Asymmetry of disciform scarring disease when one eye is treated with radiotherapy. Br J Ophthalmol 1995;79:562-8.
42. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-32.
43. Chiu-Tsao S-T, Anderson LL. Thermoluminescent dosimetry for palladium-103 seeds (model 200) in solid water phantom. Med Phys 1991;18:449-52.
44. Finger PT, Lu D, Buffa A, et al. Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys 1993;27:849-54.
45. 103Pd) plaque radiotherapy for choroidal melanoma: results of a 7-year study. Ophthalmology 1999;106:606-13.
46. Finger PT. Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 2000;84:1068-70.
47. Finger PT. Plaque radiation therapy for malignant melanoma of the iris and ciliary body. Am J Ophthalmol 2001;132:328-35.
48. Meigooni AS, Sabnis S, Nath R. Dosimetry of palladium-103 brachytherapy sources for permanent implants. Endocuriether Hypertherm Oncol 1990;6:107-17.
49. Beyer D, Nath R, Butler W, et al. American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for (103) palladium brachytherapy. The clinical research committee of the American Brachytherapy Society. Int J Radial Oncol Biol Phys 2000;47:273-5.
50. Monroe JI, Williamson JF. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed. Med Phys 2002;29:609-21.
51. Williamson JF, Coursey BM, DeWerd LA, et al. Recommendations of the American Association of Physicists on 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription. Med Phys 2000;27:634-42.
52. Bergink GJ, Deutman AF, van den Broek JF, et al. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Graefes Arch Clin Exp Ophthalmol 1994;232:591-8.
53. Brady LW, Freire JE, Longton WA, et al. Radiation therapy for macular degeneration: technical considerations and preliminary results. Int J Radiat Oncol Biol Phys 1997;39:945-8.
54. Gibbs FA Jr, Leavitt DD. A device permitting precision X-irradiation of the macula with conventional medical linear accelerator. Front Radiat Ther Oncol 2001;35:94-106.
55. Hart PM, Chakravartny V, MacKenzie G, et al. Teletherapy for subfoveal CNVM of ARMD: results of follow-up in a non-randomized study. Br J Ophthalmol 1996,80:1046-50.
56. Kobayashi H, Kobayashi K. Age-related macular degeneration: long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophthalmol 2000;130:617-35.
57. Mandai M, Takahashi M, Miyamoto H, et al. Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration. Jpn J Ophthalmol 2000;44: 530-7.
58. Mauget-Faysse M, Chiquet C, Milea D, et al. Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 1999;83:923-8.